Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Galectin Therapeutics Inc.

TRADE

NASDAQ: GALTHealthcare / Drugs - Generic / USA
6.53-0.40-5.77%Vol 1 489 8251Y Perf 247.34%
Sep 21st, 2018 16:00
BID6.31 ASK6.52
Open6.60 Previous Close6.93
Pre-Market6.60 After-Trading6.41
 -0.33 -4.76%  -0.12 -1.84%
Target Price
11.50 
Analyst Rating
Strong Buy 1.00
Potencial %
76.11 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-60/-94/-76 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-97/-100/-99 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-98/-100/-98 
Income Ranking
 —    -
Market Cap (mil)267 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
63.95 
Earnings Date
6th Nov 2018

Today's Price Range

6.226.68

 

52wk Range

1.289.49

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
40.73%
3 Months
-14.86%
6 Months
38.05%
1 Year
247.34%
3 Years
180.26%
5 Years
-30.09%

Quotes

Name / TickerPriceChg.Chg.%
GALT6.53-0.4000-5.77
AAPL218.31-1.7200-0.78
GOOG1 166.99-19.8800-1.67
MSFT114.110.54000.48
XOM85.170.35000.41
WFC54.99-0.5600-1.01
JNJ142.880.90000.63
FB163.03-2.9900-1.80
GE12.17-0.2900-2.33
JPM117.85-0.7800-0.66
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 7.30
Current Ratio 7.70
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -81.30
Leverage Ratio -1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 269.44
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -16.30
Cash Flow Per Share -0.37
Price to Tangible Book269.44
Book Value per Share0.02
Enterprise Value (in ths.)218 485
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-284.75
ROE last 12 Months 1 386.74
Return on Assets (5Y Avg) -194.45
ROA last 12 Months -156.77
Return on Capital (5Y Avg) -235.29
ROC last 12 Months -280.09
Return on invested Capital Q -280.09
Return on invested Capital Y-218.11
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.12-0.118.33
Q01 2018-0.13-0.127.69
Q04 2017-0.11-0.0736.36
Q03 2017-0.14-0.137.14
Q02 2017-0.15-0.146.67
Q01 2017-0.15-0.150.00
Q04 2016-0.16-0.1318.75
Q03 2016-0.22-0.1913.64
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.1016.67Positive
12/2018 QR-0.120.00-
12/2018 FY-0.444.35Positive
12/2019 FY-1.12-24.44Negative
Next Report Date6th Nov 2018
Estimated EPS Next Report-0.10
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume1 489 825
Shares Outstanding (in ths.)40 910
Trades Count3 663
Dollar Volume8 897 835
Avg. Volume750 715
Avg. Weekly Volume1 242 637
Avg. Monthly Volume960 574
Avg. Quarterly Volume746 472

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

78%22%

Bearish Bullish

60%40%

Bearish Bullish

59%41%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x